Sex, drugs and Parkinson's disease

被引：3

作者：

Ushe, Mwiza ^{[1
]}

Perlmutter, Joel S. ^{[1
,2
,3
,4
,5
]}

机构：

[1] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA

[3] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA

[4] Washington Univ, Sch Med, Program Phys Therapy, St Louis, MO 63110 USA

[5] Washington Univ, Sch Med, Program Occupat Therapy, St Louis, MO 63110 USA

来源：

关键词：

INCENTIVE SALIENCE; DOPAMINE; REWARD; BRAIN;

D O I：

10.1093/brain/awt022

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：371 / 373

页数：4

共 50 条

[1] Drugs for Parkinson's Disease
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1534): : 187 - 194
[2] Drugs for Parkinson's Disease
不详
[J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2021, 63 (1618): : 25 - 32
[3] Sex and Parkinson's disease
Kawulak-Krol, M.
Tomasiuk, R.
Friedman, A.
[J]. PARKINSONISM & RELATED DISORDERS, 2007, 13 : S44 - S44
[4] Sex in Parkinson's disease
Scelzo, E.
Ferrucci, R.
Raoli, V.
Ardolino, G.
Cogiamanian, F.
Barone, P.
Bertolasi, L.
Padovani, A.
Panzeri, M.
Ronconi, L.
Ciocca, M.
Priori, A.
[J]. JOURNAL OF NEUROLOGY, 2013, 260 : S138 - S138
[5] Repurposing sex steroids and related drugs as potential treatment for Parkinson's disease
Bourque, Melanie
Morissette, Marc
Di Paolo, Therese
[J]. NEUROPHARMACOLOGY, 2019, 147 : 37 - 54
[6] New drugs for Parkinson's disease
Simonson, William
[J]. GERIATRIC NURSING, 2017, 38 (03) : 244 - 245
[7] Advances in Parkinson's Disease Drugs
Di Stefano, Antonio
Marinelli, Lisa
[J]. BIOMOLECULES, 2021, 11 (11)
[8] Novel drugs for Parkinson's disease
Hubble, JP
[J]. MEDICAL CLINICS OF NORTH AMERICA, 1999, 83 (02) : 525 - +
[9] Antidiabetic drugs in Parkinson's disease
Aguirre-Vidal, Yoshajandith
Montes, Sergio
Mota-Lopez, Ana Carolina
Navarrete-Vazquez, Gabriel
[J]. CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 11
[10] Drugs of abuse and Parkinson's disease
Mursaleen, Leah R.
Stamford, Jonathan A.
[J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2016, 64 : 209 - 217